WO2007022938A3 - Compounds - Google Patents

Compounds Download PDF

Info

Publication number
WO2007022938A3
WO2007022938A3 PCT/EP2006/008205 EP2006008205W WO2007022938A3 WO 2007022938 A3 WO2007022938 A3 WO 2007022938A3 EP 2006008205 W EP2006008205 W EP 2006008205W WO 2007022938 A3 WO2007022938 A3 WO 2007022938A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
diseases
indirectly
decrease
activity
Prior art date
Application number
PCT/EP2006/008205
Other languages
French (fr)
Other versions
WO2007022938A2 (en
Inventor
Robert Gleave
William Leonard Mitchell
Lee William Page
Martin Swarbrick
Dewi John Walters
Original Assignee
Glaxo Group Ltd
Robert Gleave
William Leonard Mitchell
Lee William Page
Martin Swarbrick
Dewi John Walters
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Robert Gleave, William Leonard Mitchell, Lee William Page, Martin Swarbrick, Dewi John Walters filed Critical Glaxo Group Ltd
Publication of WO2007022938A2 publication Critical patent/WO2007022938A2/en
Publication of WO2007022938A3 publication Critical patent/WO2007022938A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

The present invention relates to novel pyridazinyl derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
PCT/EP2006/008205 2005-08-22 2006-08-18 Compounds WO2007022938A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0517188A GB0517188D0 (en) 2005-08-22 2005-08-22 Compounds
GB0517188.9 2005-08-22

Publications (2)

Publication Number Publication Date
WO2007022938A2 WO2007022938A2 (en) 2007-03-01
WO2007022938A3 true WO2007022938A3 (en) 2007-06-28

Family

ID=35098095

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/008205 WO2007022938A2 (en) 2005-08-22 2006-08-18 Compounds

Country Status (2)

Country Link
GB (1) GB0517188D0 (en)
WO (1) WO2007022938A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018433A1 (en) * 2002-08-21 2004-03-04 Glaxo Group Limited Pyrimidine derivatives and their use as cb2 modulators
WO2004018434A1 (en) * 2002-08-21 2004-03-04 Glaxo Group Limited Pyrimidine compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018433A1 (en) * 2002-08-21 2004-03-04 Glaxo Group Limited Pyrimidine derivatives and their use as cb2 modulators
WO2004018434A1 (en) * 2002-08-21 2004-03-04 Glaxo Group Limited Pyrimidine compounds

Also Published As

Publication number Publication date
GB0517188D0 (en) 2005-09-28
WO2007022938A2 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
TW200611695A (en) Pyrrolopyridine derivatives
GB0222495D0 (en) Compounds
UA83194C2 (en) Pyrimidine derivatives and their use as cb2 modulators
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
TW200638934A (en) Heteroaryl compounds as P2Y1 receptor inhibitors
LTC1781298I2 (en) Pharmaceutical compositions containing benzoxazine for the treatment of respiratory diseases
EP2305640A3 (en) Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
GEP20125565B (en) Lactam compounds and their pharmaceutical use
WO2007064883A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2007127474A3 (en) Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
HK1166983A1 (en) Solid forms comprising compounds for the treatment of diseases or disorders, compositions thereof, and use therewith
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2006058867A3 (en) Substituted pteridines for the treatment of inflammatory diseases
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
WO2008087367A3 (en) Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same
WO2007072201A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2007056366A3 (en) Compounds and compositions as ppar modulators
WO2009071689A3 (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
WO2007012479A3 (en) Benzylpiperazine derivates and their medical use
TW200726763A (en) Novel compound
AU2003260436A1 (en) Pyrimidine compounds

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06791596

Country of ref document: EP

Kind code of ref document: A2